Palifermin treatment in patients receiving high dose melphalan or BEAM prior to autologous peripheral blood stem-cell transplantation.

Sonet, Anne;Bries, G.;Meulemans, N.;Van Hoof, A.;Bron, D.;et.al.
(2006) 48th Annual Meeting of the American-Society-of-Hematology — Location: Orlando (Fl) (9.December.2006)

Files

No attached file found for this publication.

Details

Authors
  • Bries, G.
    Author
  • Meulemans, N.
    Author
  • Van Hoof, A.
    Author
  • Bosly, AndréUCLouvain
    Author
  • Delforge, M.UCLouvain
    Author
  • Bron, D.
    Author
Show more
Affiliations

Citations

Sonet, A., Bries, G., Meulemans, N., Van Hoof, A., Steel, E., André, M., Ferrant, A., Straetmans, N., Zachee, P., Robin, V., Demuynck, H., Noens, L., Bosly, A., Delforge, M., & Bron, D. (2006). Palifermin treatment in patients receiving high dose melphalan or BEAM prior to autologous peripheral blood stem-cell transplantation. Blood, 108(11), 401B-402B. https://hdl.handle.net/2078.5/139460 (Original work published 2006)